Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device

Go back to Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device
Abbott Laboratories (NYSE: ABT) Delayed: 106.67 +1.15 (1.09%)
Previous Close $105.52    52 Week High $46.38 
Open $105.69    52 Week Low $36.00 
Day High $106.86    P/E 71.11 
Day Low $104.78    EPS $1.50 
Volume 694,444